查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094856

骶髂關節融合市場：全球市場預測（2026-2032）

Sacroiliac Joint Fusion Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，骶髂關節融合市場將成長至 19.1034 億美元，複合年成長率為 12.29%。

主要市場統計數據
基準年（2025 年） 8.4842億美元
預計年份（2026年） 9.4286億美元
預測年份（2032年） 1,910,340,000 美元
複合年成長率（） 12.29%

隨著實證醫學在治療源自骶髂關節的慢性腰痛方面日益重要，骶髂關節融合術的臨床和商業性價值也日益凸顯。骶髂關節被認為是部分持續性腰痛患者的潛在疼痛來源，尤其是在腰椎融合術後、外傷、妊娠相關骨盆改變、發炎性疾病或退化性骶髂關節炎等情況下。診斷通常結合患者病歷、疼痛部位、誘發性身體檢查、影像檢查（排除其他病灶）以及影像導引下的診斷性穿刺。

此領域的發展受到以下因素的影響：微創骶髂關節融合術的持續普及、植入設計的改進、導航輔助植入技術的應用，以及保險公司在批准手術前對保守治療失敗案例的日益重視。此外，人口老化、脊椎和骨盆退化性疾病發病率上升以及介入性疼痛管理和脊椎治療的普及等人口和臨床趨勢也影響著該領域的發展。在醫院、門診手術中心以及整形外科和神經外科專科診所，骶髂關節融合術正日益成為脊椎外科和肌肉骨骼疼痛管理領域中一項重要的標靶手術。

骶髂關節融合領域的變革性變化

骶髂關節融合術正從開放性手術轉向微創、影像導引的門診手術，旨在減少組織損傷、縮短恢復時間並提高手術的可重複性。植入形狀、多孔表面、積層製造和生物整合整合策略的進步有助於實現更牢固的固定和骨整合，而精細的側位、後位和後斜位入路則拓展了手術選擇範圍，以滿足不同的解剖和臨床需求。

人工智慧對薦髂關節融合手術的累積影響

人工智慧 (AI) 正透過影像分析、工作流程最佳化、臨床決策支援和治療結果分析，開始影響骶髂關節融合術。 AI 工具可輔助進行骨盆解剖分割、識別退化性變化和術後變化、輔助規劃植入路徑，並提高術前評估的一致性。在採用導航、機器人手術或先進影像系統的醫療機構中，AI 可將 CT、透視、MRI 和電子健康記錄資料整合到更連貫的決策流程中，有助於改善手術計畫。

骶髂關節融合手術的區域分析

亞太地區脊椎醫療體係不斷擴展，人口老化大規模，對微創整形外科和神經外科手術的需求日益成長。日本、韓國、澳洲、中國和印度的手術應用模式各不相同，取決於保險報銷系統、專科醫生資源、影像診斷設備以及醫院基礎設施。在亞太地區的許多市場，骶髂關節融合術的普及與肌肉骨骼診斷、疼痛管理、創傷和退化性脊椎疾病治療以及醫療設備法規的現代化密切相關。

基於群體的骶髂關節融合手術主要分析

骶髂關節融合術在東南亞國協的普及程度各不相同，新加坡、泰國和馬來西亞等國相比該地區資源匱乏的地區，在先進脊椎外科手術方面擁有相對更優越的條件。東南亞國協開展此項手術與私立醫院網路的擴張、醫療旅遊、整形外科培訓以及影像技術的逐步普及密切相關。海灣合作理事會（GCC）國家正透過對先進外科基礎設施、脊椎專科計畫和數位醫療平台的大量投資，為微創骶髂關節融合術的開展創造有利環境，但公共部門的採購週期、報銷規定以及臨床醫生培訓仍然是影響該手術普及的關鍵因素。

各國骶髂關節融合手術進行分析。

在美國，由於脊椎外科手術網路、介入性疼痛治療​​機構、門診手術中心等設施完善，以及明確的保險覆蓋標準（通常包括「骶髂關節觀察」、「保守治療無效」和「診斷性注射確診」），人們對這種手術的認知度很高。加拿大的醫療保健體系更為集中化，且由公共資金資助，因此，能否獲得治療取決於各省的臨床路徑、專科轉診模式、影像檢查的可用性以及醫院資源的分配情況。在墨西哥，這種手術主要在私立醫院和主要大都市地區進行；而在巴西，手術則集中在擁有先進植入和微創脊椎手術專業技術的三級脊椎中心和私立醫療機構。

為行業領導者提供的實用建議

產業領導者應優先考慮實證醫學證據的收集、手術流程培訓以及符合保險公司要求的文件記錄，以促進骶髂關節融合術的推廣應用。臨床策略應著重於標準化的診斷流程，包括疼痛定位、誘發試驗、影像學檢查和影像引導下的診斷性穿刺。增加對外科培訓、屍體解剖工作坊、導航培訓以及針對特定手術方法的技術支援的投入，可以提高手術流程的一致性，並降低推廣應用的門檻。

分析方法

本報告採用結構化的二手研究途徑，重點關注檢驗的公共衛生、臨床、監管和醫療保健系統資訊來源。研究框架包括對同行評審的脊椎外科和整形外科文獻、臨床實踐指南、整形外科植入監管路徑、保險公司醫療保健政策、醫院護理模式、醫療技術評估原則以及公開的本地醫療保健基礎設施資訊的回顧。報告尤其關注檢驗的定性研究和數據支援的見解，這些見解涉及臨床應用促進因素、診斷標準、治療流程、本地可及性以及技術整合。

結論

隨著微創技術、改良植入、先進影像技術和嚴謹診斷流程的進步，骶髂關節融合術正逐漸發展成為脊椎和整形外科醫學領域一個更為獨立的分支，並重塑著慢性骶髂關節疼痛的治療模式。在臨床證據、保險公司文件、訓練有素的專家以及手術基礎設施完善的地區，骶髂關節融合術的發展機會最為顯著。儘管北美和歐洲部分地區的應用環境已較為成熟，但亞太地區、中東、拉丁美洲和非洲部分地區的醫療中心也具備應用潛力，這與這些地區醫療現代化和專家資源的可近性密切相關。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章：骶髂關節融合市場：依產品類型分類

  • 植入
    • PEEK籠
    • 鈦籠
  • 裝置
  • 擰緊
  • 桿
  • 盤子
  • 配件和耗材

第8章：骶髂關節融合術市場：依手術類型分類

  • 微創
    • 在透視下
    • 導航輔助型
  • 開放性手術

第9章：骶髂關節融合市場：依手術方式分類

  • 外部
  • 落後
  • 後外側法

第10章：骶髂關節融合市場：依固定機制分類

  • 椎間植入
  • 鋼板固定法
  • 桿件固定方法
  • 螺絲固定法

第11章：骶髂關節融合市場：依應用領域分類

  • 退化性骶髂關節炎症
  • 骶髂關節損傷
  • 腰椎融合術後薦髂關節疼痛
  • 創傷

第12章：骶髂關節融合市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章：骶髂關節融合市場：依通路分類

  • 直銷
  • 銷售代理

第14章 骶髂關節融合市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：骶髂關節融合市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 骶髂關節融合市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第18章：公司簡介

  • 4WEB Medical
  • Alevio LLC
  • Alphatec Spine, Inc.
  • Aurora Spine Corporation
  • Camber Spine Technologies, LLC
  • Captiva Spine, Inc.
  • ChoiceSpine, LLC
  • CoreLink, LLC
  • Foundation Fusion Solutions, LLC
  • Genesys Spine
  • Globus Medical, Inc.
  • Johnson & Johnson Services Inc.
  • Life Spine, Inc.
  • Medtronic plc
  • Omnia Medical, LLC
  • Orthofix Medical Inc.
  • PainTEQ
  • SI-BONE, Inc.
  • SIGNUS Medizintechnik GmbH
  • Spinal Simplicity, LLC
  • Stryker Corporation
  • SurGenTec, LLC
  • Tenon Medical, Inc.
  • VGI Medical, LLC
  • Xtant Medical
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3A2E844FDC50

The Sacroiliac Joint Fusion Market is projected to grow by USD 1,910.34 million at a CAGR of 12.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 848.42 million
Estimated Year [2026] USD 942.86 million
Forecast Year [2032] USD 1,910.34 million
CAGR (%) 12.29%

Sacroiliac joint fusion is gaining clinical and commercial relevance as healthcare systems place greater emphasis on evidence-based treatment for chronic low back pain originating from the sacroiliac joint. The sacroiliac joint is recognized as a potential pain generator in a meaningful subset of patients with persistent low back pain, particularly after lumbar fusion, trauma, pregnancy-related pelvic changes, inflammatory conditions, or degenerative sacroiliitis. Diagnosis typically relies on a combination of patient history, pain localization, provocative physical examination maneuvers, imaging to exclude competing pathology, and image-guided diagnostic injections.

The sector is shaped by the continued adoption of minimally invasive sacroiliac joint fusion techniques, implant design improvements, navigation-enabled placement, and growing payer focus on documented conservative care failure before surgical authorization. Demand is also influenced by verified demographic and clinical trends, including aging populations, rising prevalence of degenerative spine and pelvic disorders, and expanding access to interventional pain and spine care. Across hospitals, ambulatory surgery centers, and specialty orthopedic and neurosurgical practices, sacroiliac joint fusion is increasingly positioned as a targeted procedure within the broader spine surgery and musculoskeletal pain management continuum.

Transformative Shifts in the Sacroiliac Joint Fusion Landscape

The sacroiliac joint fusion landscape is moving from open surgical approaches toward minimally invasive, image-guided, and outpatient-compatible procedures designed to reduce tissue disruption, shorten recovery pathways, and improve procedural reproducibility. Advances in implant geometry, porous surfaces, additive manufacturing, and biologic integration strategies are supporting stronger fixation and osseointegration objectives, while refined lateral, posterior, and posterior-oblique approaches are expanding procedural options for different anatomical and clinical needs.

A major shift is the convergence of spine surgery, interventional pain management, and ambulatory care. Health systems are increasingly evaluating sacroiliac joint fusion within value-based care frameworks, with scrutiny on patient selection, diagnostic confirmation, functional outcomes, opioid reduction, revision risk, and total episode-of-care cost. At the same time, payer medical policies and clinical guidelines are encouraging standardized documentation, including conservative therapy history, positive provocative tests, confirmatory injections, and failure of nonoperative management. These changes are elevating the importance of clinical evidence, surgeon training, real-world outcomes tracking, and procedure-specific coding literacy.

Cumulative Impact of Artificial Intelligence on Sacroiliac Joint Fusion

Artificial intelligence is beginning to influence sacroiliac joint fusion through imaging analytics, workflow optimization, clinical decision support, and outcomes intelligence. AI-enabled tools can assist in segmenting pelvic anatomy, identifying degenerative or post-surgical changes, supporting implant trajectory planning, and improving consistency in preoperative evaluation. In facilities using navigation, robotics, or advanced imaging ecosystems, AI has the potential to strengthen procedural planning by integrating CT, fluoroscopy, MRI, and electronic health record data into more structured decision pathways.

The cumulative impact of AI is expected to be most visible in precision patient selection and longitudinal outcome monitoring. Machine learning models can help analyze pain scores, functional disability indices, comorbidities, prior lumbar fusion history, diagnostic injection response, and imaging features to identify patient profiles more likely to benefit from sacroiliac joint fusion. AI can also support claims review, documentation quality, implant inventory planning, and post-procedure surveillance for complications or revision signals. However, responsible adoption requires validated datasets, bias monitoring, clinician oversight, cybersecurity safeguards, and alignment with regulatory requirements for software used in medical decision-making.

Key Regional Insights for Sacroiliac Joint Fusion

Asia-Pacific is characterized by expanding spine care capacity, large aging populations, and growing demand for minimally invasive orthopedic and neurosurgical procedures. Japan, South Korea, Australia, China, and India show different adoption patterns based on reimbursement structures, specialist availability, imaging access, and hospital infrastructure. In many Asia-Pacific markets, sacroiliac joint fusion adoption is tied to broader improvements in musculoskeletal diagnosis, interventional pain services, trauma and degenerative spine care, and medical device regulatory modernization.

North America remains one of the most developed environments for sacroiliac joint fusion because of established spine surgery networks, advanced imaging penetration, ambulatory surgery center utilization, and payer policies that define criteria for medically necessary procedures. The region places strong emphasis on clinical evidence, coding compliance, prior authorization, and documentation of failed conservative treatment. Latin America demonstrates selective adoption, led by urban tertiary hospitals and private healthcare channels where access to advanced spine implants and minimally invasive surgical expertise is stronger, while affordability, public-sector capacity, and reimbursement variability continue to influence procedural availability.

Europe reflects a structured but heterogeneous landscape, with adoption shaped by national health technology assessment processes, hospital procurement rules, public reimbursement pathways, and clinician adherence to conservative treatment protocols before fusion. Western European countries generally have broader access to advanced imaging and spine specialists, while parts of Eastern Europe are still building procedural capacity. The Middle East is advancing through investments in specialty hospitals, spine centers, and medical tourism infrastructure, particularly in higher-income healthcare systems. Africa remains an emerging region for sacroiliac joint fusion, with availability concentrated in major urban centers and private hospitals; wider adoption is limited by surgical infrastructure, imaging access, trained specialist density, and affordability constraints.

Key Group Insights for Sacroiliac Joint Fusion

ASEAN countries present a mixed sacroiliac joint fusion environment, where Singapore, Thailand, and Malaysia tend to demonstrate stronger access to advanced spine procedures than lower-resource settings in the region. Adoption in ASEAN is closely linked to private hospital networks, medical tourism, expanding orthopedic training, and gradual improvement in diagnostic imaging availability. GCC countries are investing heavily in advanced surgical infrastructure, specialty spine programs, and digital health platforms, creating favorable conditions for minimally invasive sacroiliac joint fusion, although public-sector procurement cycles, reimbursement controls, and clinician training remain important determinants of adoption.

The European Union provides a regulated and evidence-driven framework for sacroiliac joint fusion, with medical device compliance, clinical evaluation requirements, hospital purchasing processes, and reimbursement reviews shaping product access. EU healthcare systems generally emphasize documented clinical benefit, safety, and cost-effectiveness, making registry data and post-market surveillance increasingly important. BRICS countries reflect diverse adoption conditions: China and India are expanding procedural capacity through large hospital networks and growing specialist bases, Brazil supports adoption through private and tertiary care channels, Russia maintains regional spine expertise despite procurement complexity, and South Africa offers access primarily in advanced urban centers.

G7 countries collectively represent mature healthcare environments where sacroiliac joint fusion is influenced by aging demographics, advanced spine care pathways, stringent regulatory expectations, and payer scrutiny. These markets often set reference standards for clinical evidence, reimbursement documentation, and post-market monitoring. NATO countries overlap significantly with advanced North American and European healthcare systems, but procedural access varies according to national reimbursement structures, public-private healthcare balance, military and veteran health systems, and defense-related medical infrastructure. Across these country groups, the common success factors are surgeon education, reliable imaging, standardized diagnosis, policy-compliant documentation, and demonstrable patient-reported outcome improvement.

Key Country Insights for Sacroiliac Joint Fusion

The United States shows broad procedural awareness due to established spine surgery networks, interventional pain practices, ambulatory surgery centers, and defined payer coverage criteria that commonly require documented sacroiliac joint pain, failed conservative therapy, and confirmatory diagnostic injections. Canada has a more centralized and publicly funded environment, where access depends on provincial pathways, specialist referral patterns, imaging availability, and hospital resource allocation. Mexico demonstrates adoption mainly in private hospitals and major metropolitan centers, while Brazil's activity is concentrated in tertiary spine programs and private healthcare networks with access to advanced implants and minimally invasive spine expertise.

In Europe, the United Kingdom emphasizes evidence-based commissioning and careful patient selection, while Germany benefits from strong orthopedic and spine surgery infrastructure, advanced imaging availability, and hospital-based procedural capacity. France applies structured clinical and reimbursement evaluation processes, supporting evidence-driven adoption. Italy and Spain demonstrate demand linked to aging populations and established orthopedic care, although regional healthcare budgets and hospital procurement practices influence access. Russia has specialized spine centers in major cities, with adoption shaped by procurement systems, import dynamics, and regional clinical capacity.

China is expanding spine care capabilities through large hospital systems, rising specialist training, and modernization of medical technology regulation, although access differs substantially between top-tier urban hospitals and lower-tier facilities. India presents strong long-term clinical need due to a large population, growing private hospital networks, and increasing minimally invasive spine surgery expertise, with affordability and insurance penetration remaining important barriers. Japan's aging population and advanced imaging infrastructure support careful evaluation of degenerative sacroiliac pathology, while South Korea combines high technology adoption with sophisticated orthopedic and neurosurgical services. Australia has established musculoskeletal care pathways, strong imaging access, and a mix of public and private adoption, with reimbursement and referral pathways shaping procedure utilization.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation, procedural education, and payer-aligned documentation to strengthen sacroiliac joint fusion adoption. Clinical strategies should focus on standardized diagnostic algorithms that include pain localization, provocative tests, imaging review, and image-guided diagnostic injections. Investment in surgeon training, cadaveric workshops, navigation education, and approach-specific technique support can improve procedural consistency and reduce adoption barriers.

Commercial and clinical teams should develop value dossiers centered on patient-reported outcomes, functional improvement, complication profiles, revision monitoring, opioid-use reduction, and return-to-activity measures rather than promotional claims. Device developers should continue improving implant fixation, osseointegration surfaces, instrumentation ergonomics, and compatibility with navigation or robotic workflows. Health system partners should implement registries and real-world evidence programs to support post-market surveillance and payer engagement. Leaders expanding internationally should tailor access strategies to local reimbursement rules, hospital procurement structures, regulatory requirements, specialist density, imaging infrastructure, and evidence expectations.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on validated public health, clinical, regulatory, and healthcare system sources. The research framework includes review of peer-reviewed spine surgery and orthopedic literature, clinical practice guidelines, regulatory pathways for orthopedic implants, payer medical policies, hospital care models, health technology assessment principles, and publicly available information on regional healthcare infrastructure. Emphasis is placed on verified qualitative and data-backed insights related to clinical adoption drivers, diagnostic standards, procedural pathways, regional access conditions, and technology integration.

The methodology excludes unsupported market sizing, market share calculations, and forecasting. Insights are triangulated across multiple source categories to improve reliability, including clinical evidence on sacroiliac joint pain diagnosis and fusion outcomes, healthcare reimbursement documentation requirements, medical device regulation, ambulatory surgery trends, and country-level healthcare capacity indicators. Regional, group, and country interpretations are based on observable differences in healthcare infrastructure, reimbursement design, specialist access, imaging availability, and regulatory maturity.

Conclusion

Sacroiliac joint fusion is evolving into a more defined segment of spine and orthopedic care as minimally invasive techniques, improved implants, advanced imaging, and rigorous diagnostic pathways reshape treatment delivery for chronic sacroiliac joint pain. The strongest opportunities are emerging where clinical evidence, payer documentation, trained specialists, and procedural infrastructure align. North America and parts of Europe demonstrate mature adoption conditions, while Asia-Pacific, the Middle East, Latin America, and select African centers present adoption potential tied to healthcare modernization and specialist access.

Artificial intelligence, navigation-enabled planning, real-world evidence systems, and value-based care expectations are likely to influence how sacroiliac joint fusion is selected, performed, and evaluated. Organizations that combine robust clinical validation, responsible technology integration, local access expertise, and outcome-focused education will be better positioned to support sustainable adoption. The future of sacroiliac joint fusion will depend less on procedure availability alone and more on precise diagnosis, measurable patient benefit, and alignment with healthcare system expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Sacroiliac Joint Fusion Market, by Product Type

  • 7.1. Introduction
  • 7.2. Implants
    • 7.2.1. PEEK Cage
    • 7.2.2. Titanium Cage
  • 7.3. Instruments
  • 7.4. Screws
  • 7.5. Rods
  • 7.6. Plates
  • 7.7. Accessories & Consumables

8. Sacroiliac Joint Fusion Market, by Procedure Type

  • 8.1. Introduction
  • 8.2. Minimally Invasive
    • 8.2.1. Fluoroscopy Guided
    • 8.2.2. Navigation Assisted
  • 8.3. Open Surgery

9. Sacroiliac Joint Fusion Market, by Approach

  • 9.1. Introduction
  • 9.2. Lateral
  • 9.3. Posterior
  • 9.4. Posterior-Lateral

10. Sacroiliac Joint Fusion Market, by Fixation Mechanism

  • 10.1. Introduction
  • 10.2. Interbody Devices
  • 10.3. Plate Fixation
  • 10.4. Rod Fixation
  • 10.5. Screw Fixation

11. Sacroiliac Joint Fusion Market, by Application

  • 11.1. Introduction
  • 11.2. Degenerative Sacroiliitis
  • 11.3. SIJ Disruption
  • 11.4. Post-Lumbar Fusion SIJ Pain
  • 11.5. Trauma

12. Sacroiliac Joint Fusion Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Sacroiliac Joint Fusion Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Direct
  • 13.3. Distributor

14. Sacroiliac Joint Fusion Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Sacroiliac Joint Fusion Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Sacroiliac Joint Fusion Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. 4WEB Medical
  • 18.2. Alevio LLC
  • 18.3. Alphatec Spine, Inc.
  • 18.4. Aurora Spine Corporation
  • 18.5. Camber Spine Technologies, LLC
  • 18.6. Captiva Spine, Inc.
  • 18.7. ChoiceSpine, LLC
  • 18.8. CoreLink, LLC
  • 18.9. Foundation Fusion Solutions, LLC
  • 18.10. Genesys Spine
  • 18.11. Globus Medical, Inc.
  • 18.12. Johnson & Johnson Services Inc.
  • 18.13. Life Spine, Inc.
  • 18.14. Medtronic plc
  • 18.15. Omnia Medical, LLC
  • 18.16. Orthofix Medical Inc.
  • 18.17. PainTEQ
  • 18.18. SI-BONE, Inc.
  • 18.19. SIGNUS Medizintechnik GmbH
  • 18.20. Spinal Simplicity, LLC
  • 18.21. Stryker Corporation
  • 18.22. SurGenTec, LLC
  • 18.23. Tenon Medical, Inc.
  • 18.24. VGI Medical, LLC
  • 18.25. Xtant Medical
  • 18.26. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SACROILIAC JOINT FUSION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SACROILIAC JOINT FUSION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SACROILIAC JOINT FUSION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SACROILIAC JOINT FUSION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SACROILIAC JOINT FUSION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL SACROILIAC JOINT FUSION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL SACROILIAC JOINT FUSION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PEEK CAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PEEK CAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PEEK CAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TITANIUM CAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TITANIUM CAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TITANIUM CAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SCREWS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SCREWS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACCESSORIES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ACCESSORIES & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACCESSORIES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLUOROSCOPY GUIDED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLUOROSCOPY GUIDED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLUOROSCOPY GUIDED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NAVIGATION ASSISTED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NAVIGATION ASSISTED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NAVIGATION ASSISTED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LATERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LATERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LATERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POSTERIOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POSTERIOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POSTERIOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POSTERIOR-LATERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POSTERIOR-LATERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POSTERIOR-LATERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTERBODY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTERBODY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTERBODY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLATE FIXATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLATE FIXATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLATE FIXATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROD FIXATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROD FIXATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROD FIXATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SCREW FIXATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SCREW FIXATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SCREW FIXATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DEGENERATIVE SACROILIITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DEGENERATIVE SACROILIITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DEGENERATIVE SACROILIITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SIJ DISRUPTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SIJ DISRUPTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SIJ DISRUPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POST-LUMBAR FUSION SIJ PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POST-LUMBAR FUSION SIJ PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POST-LUMBAR FUSION SIJ PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIRECT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIRECT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIRECT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DISTRIBUTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DISTRIBUTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 172. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 173. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 202. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 203. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 212. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 213. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. CANADA SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 290. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 297. ITALY SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 300. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 310. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 312. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. SPAIN SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 327. INDIA SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 330. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 332. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 334. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. INDIA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 337. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 340. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 342. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 346. JAPAN SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 347. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 348. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 350. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 352. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 353. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 354. AUSTRALIA SACROILIAC JOINT FUSION MARKET SIZE, BY AP